Morphic therapeutic to present at the jefferies virtual london healthcare conference

Waltham, mass., nov. 17, 2020 (globe newswire) -- morphic therapeutic (nasdaq: morf), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious chronic diseases, today announced that members of the morphic management are scheduled to participate in the jefferies virtual london healthcare conference with a company presentation at 2:55 pm et on wednesday, november 18, 2020.
MORF Ratings Summary
MORF Quant Ranking